Marty Glick is in his first season as the chief financial officer for the Golden State Warriors,
having been named to the position on June 27, 2011. In his role as CFO and minority
owner, Glick oversees all financial strategy, planning and accounting for the organization.
A highly-regarded former biotech executive whose affiliations have a history of innovative
success, Glick has accumulated a wealth of experience as a prominent financial figure for
several large biotech businesses during his career. He spent more than a decade (1987-
1997) at Genentech of South San Francisco, where he most recently served as vice president of finance. He also served
as executive vice president and chief financial officer of Theravance, a Bay Area-based drug discovery company, for
seven years (1998-2005) and was a co-founder and board member of Eyetech Pharmaceuticals.
Additionally, Glick was co-founder and chairman of the board of PEAK Surgical – an innovative private medical
device company – and his résumé also includes a seven-plus year stint as the chair of the Biotech Tax and Finance
A native of Chicago, Illinois, Glick earned his MBA in Finance at Kellogg School of Management (Northwestern
University), his BSBA in Accounting at Creighton University and is also a CPA and Chartered Accountant (Ontario,
You do not have the correct version of the Flash Player Plugin. Click here to get it.
NBA Media Ventures, LLC | Turner Sports Interactive, Inc.All rights reserved. No portion of NBA.com may be duplicated, redistributed or